408 related articles for article (PubMed ID: 25446057)
1. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.
Hebert A; Mikkelsen UR; Thilen U; Idorn L; Jensen AS; Nagy E; Hanseus K; Sørensen KE; Søndergaard L
Circulation; 2014 Dec; 130(23):2021-30. PubMed ID: 25446057
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of endothelin blockade in adults with Fontan physiology.
Derk G; Houser L; Miner P; Williams R; Moriarty J; Finn P; Alejos J; Aboulhosn J
Congenit Heart Dis; 2015; 10(1):E11-6. PubMed ID: 24890846
[TBL] [Abstract][Full Text] [Related]
3. The safety and effects of bosentan in patients with a Fontan circulation.
Bowater SE; Weaver RA; Thorne SA; Clift PF
Congenit Heart Dis; 2012; 7(3):243-9. PubMed ID: 22348734
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity?
Schuuring MJ; Vis JC; Bouma BJ; van Dijk AP; van Melle JP; Pieper PG; Vliegen HW; Sieswerda GT; Mulder BJ
Contemp Clin Trials; 2011 Jul; 32(4):586-91. PubMed ID: 21527360
[TBL] [Abstract][Full Text] [Related]
5. The effect of bosentan on exercise capacity in Fontan patients; rationale and design for the TEMPO study.
Hebert A; Jensen AS; Idorn L; Sørensen KE; Søndergaard L
BMC Cardiovasc Disord; 2013 May; 13():36. PubMed ID: 23663658
[TBL] [Abstract][Full Text] [Related]
6. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
Galiè N; Beghetti M; Gatzoulis MA; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
Circulation; 2006 Jul; 114(1):48-54. PubMed ID: 16801459
[TBL] [Abstract][Full Text] [Related]
7. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.
Schuuring MJ; Vis JC; van Dijk AP; van Melle JP; Vliegen HW; Pieper PG; Sieswerda GT; de Bruin-Bon RH; Mulder BJ; Bouma BJ
Eur J Heart Fail; 2013 Jun; 15(6):690-8. PubMed ID: 23361871
[TBL] [Abstract][Full Text] [Related]
8. Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation.
Agnoletti G; Gala S; Ferroni F; Bordese R; Appendini L; Pace Napoleone C; Bergamasco L
J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1468-1475. PubMed ID: 28283234
[TBL] [Abstract][Full Text] [Related]
9. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
Channick RN; Simonneau G; Sitbon O; Robbins IM; Frost A; Tapson VF; Badesch DB; Roux S; Rainisio M; Bodin F; Rubin LJ
Lancet; 2001 Oct; 358(9288):1119-23. PubMed ID: 11597664
[TBL] [Abstract][Full Text] [Related]
10. Fontan circulation: the search for targeted therapy.
Goldberg DJ; Paridon SM
Circulation; 2014 Dec; 130(23):1999-2001. PubMed ID: 25446056
[No Abstract] [Full Text] [Related]
11. Bosentan therapy for pulmonary arterial hypertension.
Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Gatzoulis MA; Landzberg M; Beghetti M; Berger RM; Efficace M; Gesang S; He J; Papadakis K; Pulido T; Galiè N;
Circulation; 2019 Jan; 139(1):51-63. PubMed ID: 30586694
[TBL] [Abstract][Full Text] [Related]
13. Effect of Ambrisentan on Exercise Capacity in Adult Patients After the Fontan Procedure.
Cedars AM; Saef J; Peterson LR; Coggan AR; Novak EL; Kemp D; Ludbrook PA
Am J Cardiol; 2016 May; 117(9):1524-32. PubMed ID: 27063478
[TBL] [Abstract][Full Text] [Related]
14. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.
Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S
Heart; 2005 Nov; 91(11):1447-52. PubMed ID: 15761050
[TBL] [Abstract][Full Text] [Related]
15. Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation.
Apostolopoulou SC; Papagiannis J; Rammos S
J Heart Lung Transplant; 2005 Aug; 24(8):1174-6. PubMed ID: 16102469
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Bosentan in patients after Fontan procedures: a double-blind, randomized controlled trial.
Shang XK; Lu R; Zhang X; Zhang CD; Xiao SN; Liu M; Wang B; Dong NG
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):534-540. PubMed ID: 27465329
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy in the prevention of failure of the Fontan circulation: a systematic review.
Oldenburger NJ; Mank A; Etnel J; Takkenberg JJ; Helbing WA
Cardiol Young; 2016 Jun; 26(5):842-50. PubMed ID: 26947621
[TBL] [Abstract][Full Text] [Related]
18. Impact of vitamin C on endothelial function and exercise capacity in patients with a Fontan circulation.
Goldstein BH; Sandelin AM; Golbus JR; Warnke N; Gooding L; King KK; Donohue JE; Yu S; Gurney JG; Goldberg CS; Rocchini AP; Charpie JR
Congenit Heart Dis; 2012; 7(3):226-34. PubMed ID: 22176653
[TBL] [Abstract][Full Text] [Related]
19. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
20. Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension.
Hatano M; Yamada H; Fukuda K; Yoshioka K; Funauchi M; Kuwana M; Sata M; Taniguchi M; Nakanishi N; Saito T; Saji T; Sasayama S
Heart Vessels; 2015 Nov; 30(6):798-804. PubMed ID: 25028167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
